Shehnaaz Suliman has filed 15 Form 4s with the SEC that we hold, for 10x Genomics, Inc. (TXG) (Director), Ultragenyx Pharmaceutical Inc. (RARE) (Director) and Alector, Inc. (ALEC) (President and COO). Across all of them we count 0 purchases worth $0 and 18 sales worth $7.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($936.1K). The largest single trade was a sale of 72,357 shares of Alector, Inc. worth $1.6M, dated 2021-12-09. Of 7 sales filed since we began reading the 10b5-1 checkbox, 7 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-10 and the latest 2026-09-24.
Counted from the Form 4 filings
this reporting owner (SEC CIK 1713070) filed on EDGAR. Values are the transaction values
as filed. See every filing on EDGAR,
or browse insider buying and
today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-27 ·
For informational purposes only, not investment advice. Privacy · Terms
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.